Region: Canada

Blackberry sees huge surge in licensing revenues after big Q4

Company reports numbers as it embarks on new hunt for licensing head

29 March 2019

Lyft has bulked its patent holdings through acquisitions, but still trails Uber

Prior to its IPO the ride-sharing company has shopped around the likes of AT&T, but analysis shows that its portfolio – while above average value – does not have the coverage of its rival

14 March 2019

WiLAN CEO departs after just months in the job

Keaton Parekh (right) has been replaced by the firm's former COO as the giant NPE struggles to find a successor to Jim Skippen

28 February 2019

Apple’s courtroom strategy shows team monetising former portfolio of Blackberry patents faces biggest licensing challenge

The iPhone maker moves for declaratory judgment claiming non infringement of grants relating to charging technology

11 February 2019

Kokes hails "fantastic first year" as NantWorks CIPO

In exclusive interview with IAM, after confirming as a speaker for IPBC Global 2019, the former BlackBerry IP chief talks in-depth about life sciences and high tech convergence - and the many patent opportunities that creates

23 January 2019

A director’s guide to modernising IP governance frameworks

Boards and directors typically prioritise non-IP issues on the corporate agenda; however, legal requirements and market activities suggest that this might be a serious misstep.

30 November 2018

Facebook goes back on the patent acquisition trail

Social media giant picks up more than 100 US assets from Provenance in a move that may be linked to ongoing litigation tussle with BlackBerry

30 October 2018

Cannabis food and drink patent war on the horizon as sector set to boom

Data analysis reveals sparsely populated IP landscape and, with many big companies yet to enter the fray, “once-in-a-generation” opportunities for innovators

26 October 2018

More change at the top for Blackberry's licensing operation

Legal function takes responsibility for monetisation as efforts to cash-in on a largely unencumbered portfolio increasingly turn to litigation

18 October 2018

Life sciences innovators to gain from “new NAFTA”, but not immediately

The recently-struck deal promises to boost IP protection for pharma innovators in North America, but it will be years until it has an impact

08 October 2018

Unlock unlimited access to all IAM content